MoneyWorks4Me

Divis Laboratories board to consider financial results

19 Oct 2012 Evaluate
Divis Laboratories has informed that a meeting of the board of directors of the company will be held on November 03, 2012, to consider and approve, the un-audited financial results for the second quarter ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..